Hyponatremia: Causes, Diagnosis & Treatment | Clinical Guide

Added:

The Debate Over Volume-Status-Based Diagnosis and Vaptan Therapy

While traditional clinical guides classify hyponatremia by volume status (hypovolemic, euvolemic, or hypervolemic), critics argue that clinical assessment of extracellular fluid volume is notoriously inaccurate and subjective. This has led to alternative diagnostic frameworks, such as the European guidelines, which de-emphasize volume status in favor of objective, biomarker-driven algorithms (using urine osmolality and sodium). Additionally, there is significant controversy surrounding the use of vasopressin receptor antagonists (vaptans) for SIADH. While some American guidelines support vaptans, European guidelines recommend against them due to concerns over hepatotoxicity, high cost, and the risk of rapid, uncontrolled sodium correction, which can cause devastating osmotic demyelination syndrome (ODS). This highlights a lack of universal consensus on optimal diagnostic and treatment paths.

Understanding of fluid compartments in the human body (intracellular vs. extracellular fluid) and the principles of osmosis and tonicity.
Basic renal physiology, specifically how the kidneys filter, reabsorb, and excrete water and sodium.
The physiological roles of Antidiuretic Hormone (ADH/vasopressin) and the Renin-Angiotensin-Aldosterone System (RAAS) in regulating blood volume and blood pressure.
Normal serum electrolyte concentrations and the fundamental role of sodium in action potentials and neuromuscular function.
The clinical management and pathophysiology of Hypernatremia (high sodium levels) to complete the study of sodium disorders.
Deep dive into the pathophysiology and prevention of Osmotic Demyelination Syndrome (formerly Central Pontine Myelinolysis) caused by rapid correction of hyponatremia.
Advanced management of Syndrome of Inappropriate Antidiuretic Hormone (SIADH), including the use of vaptans (vasopressin receptor antagonists).
Clinical application of fluid resuscitation protocols, including how to calculate free water clearance and safely administer hypertonic saline.
51.8K views824likes51:03@Medi-LecturesOriginal Release: 2021-06-17

Hyponatremia (serum sodium <135 mEq/L) is primarily caused by increased circulating ADH or renal sensitivity to ADH combined with free water intake, leading to dilutional hyponatremia. It is classified into three types based on plasma osmolality: hypertonic hyponatremia (>290 mOsm/kg) from effective osmoles, isotonic hyponatremia (275-290 mOsm/kg) as a laboratory artifact from high lipids/proteins, and hypotonic hyponatremia (<275 mOsm/kg) as true physiological hyponatremia. Further classification by volume status includes hypovolemic hyponatremia (extra-renal causes like vomiting/diarrhea, renal causes like thiazides/mineralocorticoid deficiency), hypervolemic hyponatremia (heart failure/cirrhosis/nephrotic syndrome), and euvolemic hyponatremia (SIADH being the most common cause). Clinical features include neurological symptoms from cerebral edema, with acute symptomatic hyponatremia being a medical emergency. Treatment varies by type: IV saline for hypovolemic, diuretics for hypervolemic, and underlying cause treatment for SIADH. Critical to avoid rapid correction (>8-10 mEq/L/24h) in chronic cases to prevent osmotic demyelination syndrome.